The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction.
暂无分享,去创建一个
Peter Kreiner | G Caleb Alexander | G. Alexander | Andrew J. Kolodny | P. Kreiner | D. Courtwright | C. Hwang | J. Eadie | T. W. Clark | Andrew Kolodny | David T Courtwright | Catherine S Hwang | John L Eadie | Thomas W Clark | Catherine S. Hwang | John L. Eadie | Thomas W. Clark | G. Alexander
[1] Megan E. Patrick,et al. Monitoring the Future national survey results on drug use, 1975-2017: Overview, key findings on adolescent drug use , 2016 .
[2] Nathaniel Katz,et al. Opioids for chronic noncancer pain: A position paper of the American Academy of Neurology , 2015, Neurology.
[3] A. O'Neil,et al. Using new technologies to improve the prevention and management of chronic conditions in populations. , 2015, Annual review of public health.
[4] D. Webster,et al. Effects of policies designed to keep firearms from high-risk individuals. , 2015, Annual review of public health.
[5] D. Finegood,et al. Cross-sector partnerships and public health: challenges and opportunities for addressing obesity and noncommunicable diseases through engagement with the private sector. , 2015, Annual review of public health.
[6] F. Gonzalez,et al. The accuracy of self‐reported drug ingestion histories in emergency department patients , 2015, Journal of clinical pharmacology.
[7] N. Osterrieder,et al. Herpesvirus Genome Integration into Telomeric Repeats of Host Cell Chromosomes. , 2014, Annual review of virology.
[8] Grant M. Carrow,et al. Prescriber response to unsolicited prescription drug monitoring program reports in Massachusetts , 2014, Pharmacoepidemiology and drug safety.
[9] Li Hui Chen,et al. Drug-poisoning Deaths Involving Opioid Analgesics: United States, 1999-2011. , 2014, NCHS data brief.
[10] P. Owens,et al. Hospital Inpatient Utilization Related to Opioid Overuse Among Adults, 1993–2012 , 2014 .
[11] A. Walley,et al. Expanded access to naloxone among firefighters, police officers, and emergency medical technicians in Massachusetts. , 2014, American journal of public health.
[12] H. Surratt,et al. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. , 2014, JAMA psychiatry.
[13] Thomas R Frieden,et al. Medication-assisted therapies--tackling the opioid-overdose epidemic. , 2014, The New England journal of medicine.
[14] Karin A Mack,et al. Sources of prescription opioid pain relievers by frequency of past-year nonmedical use United States, 2008-2011. , 2014, JAMA internal medicine.
[15] Preethy E. George,et al. Residential treatment for individuals with substance use disorders: assessing the evidence. , 2014, Psychiatric services.
[16] J. Lucas,et al. Summary health statistics for U.S. adults: national health interview survey, 2012. , 2014, Vital and health statistics. Series 10, Data from the National Health Survey.
[17] J. Strang,et al. Training family members to manage heroin overdose and administer naloxone: randomized trial of effects on knowledge and attitudes. , 2014, Addiction.
[18] L. Ngo,et al. Opioid utilization and opioid-related adverse events in nonsurgical patients in US hospitals. , 2014, Journal of hospital medicine.
[19] Robin D. Jackson. Drug Control Policy , 2014 .
[20] Nilay D Shah,et al. Ambulatory Diagnosis and Treatment of Nonmalignant Pain in the United States, 2000–2010 , 2013, Medical care.
[21] K. O’grady,et al. Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009. , 2013, American journal of public health.
[22] R. Merrill,et al. Unintentional Prescription Opioid-Related Overdose Deaths: Description of Decedents by Next of Kin or Best Contact, Utah, 2008–2009 , 2013, Journal of General Internal Medicine.
[23] D. Juurlink,et al. Dependence and Addiction During Chronic Opioid Therapy , 2012, Journal of Medical Toxicology.
[24] Amy L. Salisbury,et al. Neonatal neurobehavior effects following buprenorphine versus methadone exposure. , 2012, Addiction.
[25] J. McAllister,et al. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. , 2012, JAMA.
[26] T. S. Jones,et al. Community-based opioid overdose prevention programs providing naloxone - United States, 2010. , 2012, MMWR. Morbidity and mortality weekly report.
[27] J. McAllister,et al. Neonatal Abstinence Syndrome and Associated Health Care Expenditures , 2012 .
[28] Ayman Fareed,et al. Safety and Efficacy of Long-term Buprenorphine Maintenance Treatment , 2011 .
[29] S. Mackey,et al. Prescription opioid analgesics rapidly change the human brain , 2011, PAIN®.
[30] Nathaniel Katz,et al. Tampering with Prescription Opioids: Nature and Extent of the Problem, Health Consequences, and Solutions , 2011, The American journal of drug and alcohol abuse.
[31] W. Stewart,et al. Prevalence of Prescription Opioid-Use Disorder Among Chronic Pain Patients: Comparison of the DSM-5 vs. DSM-4 Diagnostic Criteria , 2011, Journal of addictive diseases.
[32] Leonard J. Paulozzi,et al. Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008. , 2011, MMWR. Morbidity and mortality weekly report.
[33] H. Jones,et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. , 2010, The New England journal of medicine.
[34] Joseph A Boscarino,et al. Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system. , 2010, Addiction.
[35] L. Becerra,et al. Alterations in brain structure and functional connectivity in prescription opioid-dependent patients. , 2010, Brain : a journal of neurology.
[36] C. Banta-Green,et al. Problems and concerns of patients receiving chronic opioid therapy for chronic non-cancer pain , 2010, PAIN®.
[37] A. Lipman,et al. Opioid‐induced bowel disorders and narcotic bowel syndrome in patients with chronic non‐cancer pain , 2010, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[38] H. Hagan,et al. Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities. , 2010, The Journal of infectious diseases.
[39] S. Van Uum,et al. The effects of opioids and opioid analogs on animal and human endocrine systems. , 2010, Endocrine reviews.
[40] B. Psaty,et al. Relationship of Opioid Use and Dosage Levels to Fractures in Older Chronic Pain Patients , 2010, Journal of general internal medicine.
[41] C. Rutter,et al. Trends in long‐term opioid therapy for chronic non‐cancer pain , 2009, Pharmacoepidemiology and drug safety.
[42] Leonard J Paulozzi,et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. , 2008, JAMA.
[43] Daniel H Angres,et al. The disease of addiction: origins, treatment, and recovery. , 2008, Disease-a-month : DM.
[44] E. Wish,et al. Perceived Harmfulness Predicts Nonmedical Use of Prescription Drugs Among College Students: Interactions with Sensation-Seeking , 2008, Prevention Science.
[45] John Lewis,et al. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. , 2008, Pain medicine.
[46] William J. Kowalczyk,et al. Abuse Liability of Prescription Opioids Compared to Heroin in Morphine-Maintained Heroin Abusers , 2008, Neuropsychopharmacology.
[47] Bridget A. Martell,et al. Systematic Review: Opioid Treatment for Chronic Back Pain: Prevalence, Efficacy, and Association with Addiction , 2007, Annals of Internal Medicine.
[48] L. Hourani,et al. Results from the 2008 National Survey on Drug Use and Health: National Findings , 2007 .
[49] M. Etminan,et al. Psychotropic Medications and the Risk of Fracture , 2007, Drug safety.
[50] E. Bruera,et al. Critical issues on opioids in chronic non-cancer pain: An epidemiological study , 2006, Pain.
[51] Martin S. Angst,et al. Opioid-induced Hyperalgesia: A Qualitative Systematic Review , 2006, Anesthesiology.
[52] R. Poulton,et al. Xerostomia and medications among 32-year-olds , 2006, Acta odontologica Scandinavica.
[53] K. Seal,et al. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: A pilot intervention study , 2005, Journal of Urban Health.
[54] M. Leamon,et al. High-dose methadone maintenance in pregnancy: maternal and neonatal outcomes. , 2005, American journal of obstetrics and gynecology.
[55] Don C Des Jarlais,et al. HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services. , 2005, American journal of public health.
[56] R. Mattick,et al. Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD). , 2004, Addiction.
[57] W. Ling,et al. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. , 2003, The New England journal of medicine.
[58] M. Heilig,et al. 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial , 2003, The Lancet.
[59] D. Courtwright. Dark Paradise: A History of Opiate Addiction in America , 2001 .
[60] Y I Hser,et al. A 33-year follow-up of narcotics addicts. , 2001, Archives of general psychiatry.
[61] Patrick M. O'Malley,et al. Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2004. , 2003 .
[62] M. Stitzer,et al. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. , 2000, The New England journal of medicine.
[63] Hall,et al. Methadone maintenance for opioid dependence , 2000, JAMA.
[64] M. Stitzer,et al. Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial. , 1999, JAMA.
[65] W. Ling,et al. Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. , 1998, Addiction.
[66] D. Carr,et al. The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and the American Pain Society. , 1998, The Clinical journal of pain.
[67] J. N. Campbell. APS 1995 Presidential address , 1996 .
[68] R. Portenoy. Opioid therapy for chronic nonmalignant pain , 1996 .
[69] Michael C. Brody,et al. Physicians' attitudes and practices regarding the long-term prescribing of opioids for non-cancer pain , 1994, Pain.
[70] Adam M. Samaha,et al. Admin , 1988 .
[71] Russell K. Portenoy,et al. Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases , 1986, Pain.
[72] S. Perry,et al. Management of pain during debridement: a survey of U.S. burn units , 1982, PAIN.
[73] S W Hinkley,et al. Drug abuse warning network. , 1981, Archives of general psychiatry.
[74] H. Jick,et al. Addiction rare in patients treated with narcotics. , 1980, The New England journal of medicine.
[75] S. Diamond,et al. Drug Dependency in Patients with Chronic Headaches , 1977, Headache.
[76] R. Dupont,et al. The dynamics of a heroin addiction epidemic. , 1973, Science.
[77] N. W. Barker,et al. The natural history of a heroin epidemic. , 1972, American journal of public health.